AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iRADIOLOGY Article
PDF (1.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

An in situ self‐assembled peptide derivative for inhibition of glutathione synthesis and selective enhancement of tumor radiotherapy

Xinyan Gong1,Benhang Cui1,Paiyun Li2Jie Gao1,3Yang Gao1Xiaoyao Cai1Hang Wang1Wenxue Zhang2( )Cuihong Yang1 ( )
Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Chinese Academy of Medical Sciences, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Radiation Oncology Department, Tianjin Medical University General Hospital, Tianjin, China
Department of Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Xinyan Gong and Benhang Cui are co‐first authors and they have contributed equally in this work.

Show Author Information

Graphical Abstract

Inhibition of glutathione (GSH) synthesis in cancer cells considerably improves the efficacy of reactive oxygen species‐related tumor therapy. Herein, a novel in situ self‐assembling peptide derivative (Nano‐BSO@ in situ) is constructed for the inhibition of GSH synthesis and selective enhancement of ROS‐related radiotherapy treatment of tumor cells with high alkaline phosphatase expression.

Abstract

Background

Inhibition of glutathione (GSH) synthesis in cancer cells considerably improves the efficacy of reactive oxygen species (ROS)‐related tumor therapy. Self‐assembled peptide derivatives can facilitate the efficient delivery and accumulation of small molecular drugs in cancer cells.

Methods

Self‐assembling modules were covalently linked to the GSH‐ biosynthesis inhibitor L‐buthionine sulfoximine (BSO) by solid‐phase synthesis to form the self‐assembling peptide derivative Nap‐DFDFpY‐GG‐BSO (Nano‐BSO@ in situ). Subsequently, its enzyme‐instructed self‐assembly in vitro and on cell surfaces were confirmed, and its intracellular GSH depletion and radiotherapy‐sensitizing effects were determined.

Results

Nano‐BSO@ in situ successfully self‐assembles into a hydrogel with a nanofibrous microstructure upon incubation with alkaline phosphatase (ALP) at a critical concentration of 9.84 μM. Furthermore, it selectively self‐assembles in situ on HeLa cells with high ALP expression. At a concentration of 50 μM, Nano‐BSO@ in situ decreases intracellular GSH levels by 80%, ~2.3 times more than free BSO. Meanwhile, pretreatment of HeLa cells with 50 μM Nano‐BSO@ in situ for 24 h results in a radiotherapy sensitization enhancement ratio to γ‐rays of 2.09.

Conclusions

A novel in situ self‐assembling peptide derivative for GSH depletion and selective enhancement of tumor radiotherapy was constructed. The excellent GSH‐depletion ability and remarkable radiotherapy‐enhancement performance indicate that Nano‐BSO@ in situ is a promising selective sensitizer for ROS‐related treatment of tumor cells with high ALP expression.

References

[1]

Cadet J, Wagner JR. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harbor Perspect Biol. 2013;5(2):a012559. https://doi.org/10.1101/cshperspect.a012559

[2]

Nass K. Radiation damage in protein crystallography at X‐ray free‐electron lasers. Acta Crystallogr D Struct Biol. 2019;75(Pt 2):211–218. https://doi.org/10.1107/s2059798319000317

[3]

Ahmed M, Ahmed R. Radiation in gastroenterology. Gastroenterol Res. 2022;15(6):285–296. https://doi.org/10.14740/gr1567

[4]

Hall S, Rudrawar S, Zunk M, Bernaitis N, Arora D, McDermott C, et al. Protection against radiotherapy‐induced toxicity. Antioxidants. 2016;5(3):22. https://doi.org/10.3390/antiox5030022

[5]

Guo X, Cheng Y, Zhao X, Luo Y, Chen J, Yuan WE. Advances in redox‐responsive drug delivery systems of tumor microenvironment. J Nanobiotechnol. 2018;16(1):74. https://doi.org/10.1186/s12951-018-0398-2

[6]

Liu R, Bian Y, Liu L, Liu L, Liu X, Ma S. Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review). Int J Mol Med. 2022;49(5):65. https://doi.org/10.3892/ijmm.2022.5121

[7]

Lan M, Zhao S, Liu W, Lee CS, Zhang W, Wang P. Photosensitizers for photodynamic therapy. Adv Healthcare Mater. 2019;8(13):e1900132. https://doi.org/10.1002/adhm.201900132

[8]

Xin J, Deng C, Aras O, Zhou M, Wu C, An F. Chemodynamic nanomaterials for cancer theranostics. J Nanobiotechnol. 2021;19(1):192. https://doi.org/10.1186/s12951-021-00936-y

[9]

Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054–81. https://doi.org/10.1080/15548627.2020.1810918

[10]

Liu B, Bian Y, Yuan M, Zhu Y, Liu S, Ding H, et al. L‐buthionine sulfoximine encapsulated hollow calcium peroxide as a chloroperoxidase nanocarrier for enhanced enzyme dynamic therapy. Biomaterials. 2022;289:121746. https://doi.org/10.1016/j.biomaterials.2022.121746

[11]

Lee H, To NB, Kim M, Nguyen YT, Cho SK, Choi HK. Metabolic and lipidomic characterization of radioresistant MDA‐MB‐231 human breast cancer cells to investigate potential therapeutic targets. J Pharm Biomed Anal. 2022;208:114449. https://doi.org/10.1016/j.jpba.2021.114449

[12]

Liu T, Xiong CF, Zhang LJ, Jiao G, Shi H, Feng J, et al. Boosting doxorubicin‐induced mitochondria apoptosis for the monodrug‐mediated combination of chemotherapy and chemodynamic therapy. Adv Healthcare Mater. 2023;12(3):e2202045. https://doi.org/10.1002/adhm.202202045

[13]

Zheng Y, Wang W, Gao Y, Zhang R, Wu D, Yu L, et al. Nanosonosensitizers‐engineered injectable thermogel for augmented chemo‐sonodynamic therapy of melanoma and infected wound healing. Mater Today Bio. 2023;20:100621. https://doi.org/10.1016/j.mtbio.2023.100621

[14]

Cai PY, Ma ML, Zhang YF, Zhou ZX, Wang Y, He LP, et al. Inhibition of glutathione metabolism can limit the development of pancreatic cancer. World J Stem Cell. 2022;14(5):362–4. https://doi.org/10.4252/wjsc.v14.i5.362

[15]

Kitching M, Inguva S, Ramani M, Gao Y, Marsili E, Cahill P. Biosynthesis of gold nanoparticles by vascular cells in vitro. Front Microbiol. 2022;13:813511. https://doi.org/10.3389/fmicb.2022.813511

[16]

Wei Y, Wang Z, Yang J, Xu R, Deng H, Ma S, et al. Reactive oxygen species/photothermal therapy dual‐triggered biomimetic gold nanocages nanoplatform for combination cancer therapy via ferroptosis and tumor‐associated macrophage repolarization mechanism. J Colloid Interface Sci. 2022;606(Pt 2):1950–1965. https://doi.org/10.1016/j.jcis.2021.09.160

[17]

Zhu J, Jiao A, Li Q, Lv X, Wang X, Song X, et al. Mitochondrial Ca2+‐overloading by oxygen/glutathione depletion‐boosted photodynamic therapy based on a CaCO3 nanoplatform for tumor synergistic therapy. Acta Biomater. 2022;137:252–61. https://doi.org/10.1016/j.actbio.2021.10.016

[18]

Xu J, Zhang J, Song J, Liu Y, Li J, Wang X, et al. Construction of multifunctional mesoporous silicon nano‐drug delivery system and study of dual sensitization of chemo‐photodynamic therapy in vitro and in vivo. J Colloid Interface Sci. 2022;628(Pt B):271–85. https://doi.org/10.1016/j.jcis.2022.08.100

[19]

Wang H, Yang W, Bian K, Zeng W, Jin X, Ouyang R, et al. Oxygen‐deficient BiOCl combined with l‐buthionine‐sulfoximine synergistically suppresses tumor growth through enhanced singlet oxygen generation under ultrasound irradiation. Small. 2022;18(9):e2104550. https://doi.org/10.1002/smll.202104550

[20]

Yang Z, Qiao C, Jia Q, Chen Z, Wang X, liu X, et al. Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy. Theranostics. 2022;12(14):6143–54. https://doi.org/10.7150/thno.75837

[21]

Yu J, Xiao H, Yang Z, Qiao C, Zhou B, Jia Q, et al. A potent strategy of combinational blow toward enhanced cancer chemo‐photodynamic therapy via sustainable GSH elimination. Small. 2022;18(9):e2106100. https://doi.org/10.1002/smll.202106100

[22]

Pei Z, Lei H, Cheng L. Bioactive inorganic nanomaterials for cancer theranostics. Chem Soc Rev. 2023;52(6):2031–81. https://doi.org/10.1039/d2cs00352j

[23]

Yang Y, Yang T, Chen F, Zhang C, Yin B, Yin X, et al. Degradable magnetic nanoplatform with hydroxide ions triggered photoacoustic, MR imaging, and photothermal conversion for precise cancer theranostic. Nano Lett. 2022;22(8):3228–35. https://doi.org/10.1021/acs.nanolett.1c04804

[24]

Tang L, Zhang A, Zhang Z, Zhao Q, Li J, Mei Y, et al. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy. Cancer Commun. 2022;42(2):141–63. https://doi.org/10.1002/cac2.12255

[25]

Kang Y, Wang S, Fan J, Peng X. Progress in inorganic nanomedicine carriers for tumor diagnosis and treatments. CIESC J. 2018;69(1):128–40.

[26]

Liu N, Zhu L, Li Z, Liu W, Sun M, Zhou Z. In situ self‐assembled peptide nanofibers for cancer theranostics. Biomater Sci. 2021;9(16):5427–36. https://doi.org/10.1039/d1bm00782c

[27]

Morita K, Nishimura K, Yamamoto S, Shimizu N, Yashiro T, Kawabata R, et al. In situ synthesis of an anticancer peptide amphiphile using tyrosine kinase overexpressed in cancer cells. JACS Au. 2022;2(9):2023–8. https://doi.org/10.1021/jacsau.2c00301

[28]

Gao Y, Li Y, Cao H, Jia H, Wang D, Ren C, et al. Hypertoxic self‐assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis. J Nanobiotechnol. 2022;20(1):390. https://doi.org/10.1186/s12951-022-01604-5

[29]

Zhou J, Xu B. Enzyme‐instructed self‐assembly: a multistep process for potential cancer therapy. Bioconjugate Chem. 2015;26(6):987–99. https://doi.org/10.1021/acs.bioconjchem.5b00196

[30]

Li X, Wang Y, Zhang Y, Yang Z, Gao J, Shi Y. Enzyme‐instructed self‐assembly (EISA) assists the self‐assembly and hydrogelation of hydrophobic peptides. J Mater Chem B. 2022;10(17):3242–7. https://doi.org/10.1039/d2tb00182a

[31]

Gong Z, Zhou B, Liu X, Cao J, Hong Z, Wang J, et al. Enzyme‐induced transformable peptide nanocarriers with enhanced drug permeability and retention to improve tumor nanotherapy efficacy. ACS Appl Mater Interfaces. 2021;13(47):55913–27. https://doi.org/10.1021/acsami.1c17917

[32]

Xie L, Ding Y, Zhang X, Zhang Z, Zeng S, Wang L, et al. A cascade‐targeted enzyme‐instructed peptide self‐assembly strategy for cancer immunotherapy through boosting immunogenic cell death. Small Methods. 2023;7(5):e2201416. https://doi.org/10.1002/smtd.202201416

[33]

Ji S, Gao H, Mu W, Ni X, Yi X, Shen J, et al. Enzyme‐instructed self‐assembly leads to the activation of optical properties for selective fluorescence detection and photodynamic ablation of cancer cells. J Mater Chem B. 2018;6(17):2566–73. https://doi.org/10.1039/c7tb02685d

[34]

Tesauro D, Accardo A, Diaferia C, Milano V, Guillon J, Ronga L, et al. Peptide‐based drug‐delivery systems in biotechnological applications: recent advances and perspectives. Molecules. 2019;24(2):351. https://doi.org/10.3390/molecules24020351

[35]

Tan W, Zhang Q, Wang J, Yi M, He H, Xu B. Enzymatic assemblies of thiophosphopeptides instantly target Golgi apparatus and selectively kill cancer cells. Angew Chem Int Ed. 2021;60(23):12796–801. https://doi.org/10.1002/anie.202102601

[36]

Hou X, Yang L, Li P, Liu J, Zhang Y, Wang Q, et al. In situ self‐assembly supramolecular antagonist reinforces radiotherapy by inhibiting tumor apoptosis evasion. Adv Funct Mater. 2023;33:2302697. https://doi.org/10.1002/adfm.202302697

[37]

Luo Y, Yan P, Li X, Hou J, Wang Y, Zhou S. pH‐sensitive polymeric vesicles for GOx/BSO delivery and synergetic starvation‐ferroptosis therapy of tumor. Biomacromolecules. 2021;22(10):4383–94. https://doi.org/10.1021/acs.biomac.1c00960

[38]

Zhong H, Huang PY, Yan P, Chen P, Shi Q, Zhao Z, et al. Versatile nanodrugs containing glutathione and heme oxygenase 1 inhibitors enable suppression of antioxidant defense system in a two‐pronged manner for enhanced photodynamic therapy. Adv Healthcare Mater. 2021;10(19):e2100770. https://doi.org/10.1002/adhm.202100770

[39]

Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion‐augmented cancer therapy. Chem Soc Rev. 2021;50(10):6013–41. https://doi.org/10.1039/d0cs00718h

iRADIOLOGY
Pages 199-208
Cite this article:
Gong X, Cui B, Li P, et al. An in situ self‐assembled peptide derivative for inhibition of glutathione synthesis and selective enhancement of tumor radiotherapy. iRADIOLOGY, 2023, 1(3): 199-208. https://doi.org/10.1002/ird3.31

468

Views

13

Downloads

3

Crossref

Altmetrics

Received: 27 May 2023
Accepted: 30 July 2023
Published: 11 September 2023
© 2023 The Authors. Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Return